Literature DB >> 20237357

Clinical trials that explicitly exclude gay and lesbian patients.

Brian L Egleston, Roland L Dunbrack, Michael J Hall.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20237357      PMCID： PMC2875120          DOI： 10.1056/NEJMc0912600

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Substance use in lesbian, gay, and bisexual populations: an update on empirical research and implications for treatment.

Authors:  Kelly E Green; Brian A Feinstein
Journal:  Psychol Addict Behav       Date:  2011-11-07

2.  Health-related quality of life in breast cancer survivors of different sexual orientations.

Authors:  Ulrike Boehmer; Mark Glickman; Jacqui Milton; Michael Winter
Journal:  Qual Life Res       Date:  2011-06-10       Impact factor: 4.147

3.  Representation of lesbian, gay, and bisexual people in clinical cancer trials.

Authors:  Jennifer M Jabson; John R Blosnich
Journal:  Ann Epidemiol       Date:  2012-10-10       Impact factor: 3.797

4.  Characteristics of clinical trials that require participants to be fluent in English.

Authors:  Brian L Egleston; Omar Pedraza; Yu-Ning Wong; Roland L Dunbrack; Candace L Griffin; Eric A Ross; J Robert Beck
Journal:  Clin Trials       Date:  2015-07-07       Impact factor: 2.486

5.  Time to Change: Supporting Sexual and Gender Minority People-An Underserved, Understudied Cancer Risk Population.

Authors:  Juno Obedin-Maliver
Journal:  J Natl Compr Canc Netw       Date:  2017-11       Impact factor: 11.908

6.  Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible.

Authors:  Brian L Egleston; Omar Pedraza; Yu-Ning Wong; Candace L Griffin; Eric A Ross; J Robert Beck
Journal:  Contemp Clin Trials Commun       Date:  2018-01-31

Review 7.  Vulvodynia: a consideration of clinical and methodological research challenges and recommended solutions.

Authors:  Serena Corsini-Munt; Kate M Rancourt; Justin P Dubé; Meghan A Rossi; Natalie O Rosen
Journal:  J Pain Res       Date:  2017-10-09       Impact factor: 3.133
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.